Orasure Technologies (OSUR) Cash & Equivalents (2010 - 2025)
Orasure Technologies (OSUR) reported Cash & Equivalents of $199.3 million for Q4 2025, down 25.58% on a YoY basis from $267.8 million in Q4 2024, and down 7.95% sequentially from $216.5 million in Q3 2025.
Orasure Technologies (OSUR) Cash & Equivalents (2010 - 2025) Analysis & Trends
Orasure Technologies (OSUR) has 16 years of Cash & Equivalents data on file, last reported at $199.3 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 25.58% year-over-year to $199.3 million; the trailing twelve-month figure through Dec 2025 stood at $199.3 million (down 25.58% YoY), and the FY2025 full-year result was $199.3 million, down 25.58% from the prior year.
- Cash & Equivalents retreated to $199.3 million in Q4 2025, from $216.5 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $290.4 million in Q4 2023 to a low of $66.2 million in Q2 2022.
- A 5-year average of $180.9 million and a median of $192.6 million in 2023 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents tumbled 60.2% in 2022 and soared 245.8% in 2023, its largest moves.
- Tracing OSUR's Cash & Equivalents over 5 years: stood at $116.8 million in 2021, then retreated by 28.08% to $84.0 million in 2022, then soared by 245.8% to $290.4 million in 2023, then retreated by 7.8% to $267.8 million in 2024, then declined by 25.58% to $199.3 million in 2025.
- Business Quant data shows OSUR's Cash & Equivalents at $199.3 million in Q4 2025, $216.5 million in Q3 2025, and $234.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Orasure Technologies | 294.21 Mn | 94.93 Mn | - | 199.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 199.28 Mn |
| Sep 30, 2025 | 216.48 Mn |
| Jun 30, 2025 | 234.58 Mn |
| Mar 31, 2025 | 247.57 Mn |
| Dec 31, 2024 | 267.76 Mn |
| Sep 30, 2024 | 278.57 Mn |
| Jun 30, 2024 | 258.24 Mn |
| Mar 31, 2024 | 247.15 Mn |
| Dec 31, 2023 | 290.41 Mn |
| Sep 30, 2023 | 217.53 Mn |
| Jun 30, 2023 | 185.94 Mn |
| Mar 31, 2023 | 90.19 Mn |
| Dec 31, 2022 | 83.98 Mn |
| Sep 30, 2022 | 75.21 Mn |
| Jun 30, 2022 | 66.16 Mn |
| Mar 31, 2022 | 70.72 Mn |
| Dec 31, 2021 | 116.76 Mn |
| Sep 30, 2021 | 134.96 Mn |
| Jun 30, 2021 | 158.12 Mn |
| Mar 31, 2021 | 177.68 Mn |